IPCA Laboratories
Akshyada Vaje is a professional with experience in regulatory affairs and research and development, currently serving as a Junior Officer in Regulatory Affairs at Themis Medicare Limited since October 2022, focusing on EDQM and USFDA guidelines with expertise in DMF preparation for regulated markets. Prior to this role, Akshyada worked as a Regulatory Affairs Trainee at Royal Pharma R.P, contributing to DMF filing and document verification while staying updated with ICH guidelines. Akshyada's career began at Mac-Chem Product (India) Pvt Ltd, where significant expertise was developed as a Scientific Officer in R&D, particularly in Intellectual Property Rights pertaining to patents. Educational qualifications include an Advanced Post Graduate Diploma in Regulatory Affairs from the Institute of Pharmaceutical Management Dombivali and an MSc in Organic Chemistry from Late Shri Vishnu Waman Thakur College of Science.
This person is not in the org chart
This person is not in any teams
IPCA Laboratories
3 followers
Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.